Beyond Disease Management: Strategies for Improving Patient Care and Cutting Costs
Posted on: Wednesday, 2 January 2008, 12:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c78297) has announced the addition of new Decision Resources report Beyond Disease Management: Strategies for Improving Patient Care and Cutting Costs to their offering.
Introduction
Disease management has become a common term in the U.S. health care system. Yet, the more widely the term has been adopted, the more diffuse the definition of this health care strategy has become. Whatever the actual definition, many employers regard cost-containment as a key objective of DM initiatives. DM activity is focused largely on several highly prevalent chronic disorders--diabetes, asthma, hypertension, and dyslipidemia. Manufacturers of therapies need to prepare for the impact of DM on these markets.
Get the Answers You Need to Shape Your Strategy
- A 2006 survey found that 76% of employers saw a connection between employees' health status and employees' productivity. How can pharmaceutical companies underscore the positive impact of good health on productivity?
- The most basic challenge in recruiting participants for any form of care management program is identifying suitable candidates for enrollment. How do health plans stratify patients into risk categories? How do they use this information to project health care costs for patients?
- Disease management programs will likely alter established prescribing patterns. What effects will these programs have on drug sales? Which classes will be most affected?
- For most employers, cost-containment is an essential objective of care management. How do companies rate the effectiveness of these plans as a cost-cutting measure?
Scope
- Disease management overview: definition and evolution of disease management and related strategies.
- Employers' views on disease management: findings from an employer health benefit survey.
- Challenges of patient enrollment: identifying candidates, persuading members to sign up for the program, whether to offer incentives to employees.
- Disease management in Medicare: how to apply the DM concept to Medicare beneficiaries.
- State initiative: several state governments have begun to explore the potential of DM.
- Outlook: implications of disease management for the pharmaceutical industry.
Content Outline:
Executive Summary
Strategic Considerations
Stakeholder Implications
Introduction
Evolution of Disease Management and Related Strategies
Growing Demand for Disease Management and Related Strategies
Challenges of Patient Enrollment
Employers' Views on Disease Management
Medicare Initiatives
Medicaid and State Initiatives
Support from CMS
State Initiatives
Outlook and Implications for the Pharmaceutical Industry
Sidebars
What Is Disease Management?
Florida Gives Manufacturer-Sponsored Disease Management Programs a Second Chance
Tables
1. U.S. Employers' Actual and Potential Use of Select Care Management Measures
2. Pharmaceutical Manufacturer-Sponsored Disease Management Programs Certified by the National Committee for Quality Assurance, November 2007
Figures
1. Percentage of U.S. Employers of Various Sizes That Offer Health Benefits and Disease Management Programs, 2006
2. Coverage of Key Indications in U.S. Employers' Disease Management Programs, 2006
3. Coverage of Select Indications in Disease Management Programs of Health Maintenance Organizations That Offer Disease Management, 2006
4. U.S. Employers' Perceptions of the Effectiveness of Disease Management as a Cost-Containment Measure, 2007
Companies Mentioned:
- Aetna Life Insurance
- AstraZeneca
- Bristol-Myers Squibb
- CIGNA Healthcare
- Congressional Budget Office
- Eli Lilly
- ERISA Industry Council
- Foundation for Managed Care Pharmacy
- Genentech
- GlaxoSmithKline
- Health Dialog Services
- Health Research and Educational Trust
- Healthways
- Hewitt Associates
- HSM Group
- Humana XLHealth
- Kaiser Family Foundation
- LifeMasters Supported SelfCare
- McKesson Health Solutions
- Merck
- Monsanto
- National Association of Manufacturers
- Pfizer
- Pharmacia (now part of Pfizer)
- PricewaterhouseCoopers
- Rhône-Poulenc Rorer (now part of Sanofi -Aventis)
- Schering-Plough
- SHPS, Inc.
- United HealthCare Services
- Verispan
- Visiting Nurse Service of New York
- Wyeth
For more information visit http://www.researchandmarkets.com/reports/c78297
Source: Business Wire
Related Articles
- CMSA Delivers Important Message to Congress: Case Management Services Improve Patient Care and Should Be Key Strategy in Health Care Reform Initiatives
- Several Minnesota Medical Groups Improve Care for Patients Served by Minnesota Health Care Programs, but Disparities Gap Remains
- Acumentra Health Issues Report on Washington's Medicaid Managed Care Program
- Connecticut Employers Commit to National Initiative for Improving Quality and Value in Health Care
- Rhode Island Employers Commit to National Initiative for Improving Quality and Value in Health Care
- Health Dialog Reaches One Year Milestone for Medicare Health Support Pilot Program in Western Pennsylvania
- Lyons Ambulance Service Supports Beverly Hospital's Emergency Department With a $100,000 Gift As Part of Northeast Health Foundation's Care You Deserve Initiative
- AvMed Health Plans' Care Management and Health Improvement Programs Receive Quality ``Distinction'' Award From NCQA
- Aetna Makes It Simpler and Easier for Consumers to Track and Manage Personal Health Care Expenses
- Increasing Access to Health Care: Examination of Hospital Community Benefits and Free Care Programs
 |
 |
User Comments (0)
RSS Feeds